ChristopherRobertPalmaMDScM(He/Him)

Rheumatology • Brighton, NY

Lupus & Related, Rheumatoid Arthritis & Related, Vasculitis

Assistant Professor of Medicine

Join to view full profile

Dr. Palma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Palma's full profile

Already have an account?

Office
601 elmwood avenue
Brighton, NY 14620
Phone+1 585-486-0901
Is this information wrong?

Education & Training

University of RochesterFellowship, Rheumatology, 2014 - 2016
University of RochesterResidency, Internal Medicine, 2011 - 2014
University of Rochester School of Medicine and DentistryClass of 2011
Johns Hopkins Bloomberg School of Public HealthScM, Microbiology and Immunology, 2005 - 2007
Johns Hopkins UniversityScM, 2005 - 2007
Yale UniversityBS, Biology, 2001 - 2005
Yale UniversityB.S., 2001 - 2005

Certifications & Licensure

NY State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Fellow American College of Rheumatology, 2016
Fellow American Board of Internal Medicine, 2014
Fellow American College of Medicine, 2014
George H whippe Award University of Rochester School of Medicine, 2010
Tettleman Travel Scholarship Yale University, 2004
Join now to see all

Clinical Trials

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA Start of enrollment: 2018 Oct 15
Terminated
Phase 2
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders Start of enrollment: 2021 Aug 13
Completed
Phase 2
Immune Modulators for Treating COVID-19 Start of enrollment: 2020 Oct 15
Completed
Phase 3
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) Start of enrollment: 2020 May 24
Terminated
Phase 3
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 Start of enrollment: 2020 Jun 10
Completed
Phase 1, Phase 2
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis Start of enrollment: 2019 Jan 24
Active, not recruiting
Phase 3
A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 Start of enrollment: 2021 Sep 09
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

17 citations
Characterization of di-, tri- and tetranucleotide microsatellite markers with perfect repeats for Trypanosoma brucei and related species
Oliver Balmer, Christopher Palma, Annette MacLeod, Adalgisa Caccone> ;Molecular Ecology Notes. 2006 Jun 1
12 citations
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
Lindsay Rein, Karel Calero, Ronak Shah, Charles Ojielo, Kristin M Hudock, Saba Lodhi, Farid Sadaka, Shashi Bellam, Christopher Palma, David N Hager, Jeannie Daniel, Ri...> ;Critical Care Medicine. 2022 Dec 1
7 citations
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, Anne M Lachiewicz, Martin Maillo, Jane A O'Halloran, Cynthia Boucher, P Brian Smith, Matthew W McCarthy, Patricia Se...> ;Medrxiv. 2022 Sep 26
9 citations
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, Matthew W McCarthy, Emily R Ko, Patricia Segura Nunez, Cynthia Boucher, P Brian Smith, Reynold A Panettieri, Sabina Men...> ;Medrxiv. 2022 Sep 26
Risk factors for the development of cardiovascular events within one year from the diagnosis of giant cell arteritis.
Anthony Ocon, Christopher Palma> ;Clinical and Experimental Rheumatology. 2021 Jun 25
26 citations
SARS CoV-2 infection among patients using immunomodulatory therapies.
Kevin L. Winthrop, Amanda E Brunton, Susan E. Beekmann, Philip M. Polgreen, John W Baddley, Kenneth G. Saag, Cassandra Calabrese, Leonard H. Calabrese, Philip Robinson...> ;Annals of the Rheumatic Diseases. 2021 Feb 1
Fibrosis, Thrombosis, and Dacrocytosis: An Unusual Case of Male Systemic Lupus Erythematosus.
Ming Qi Wu, Matthew Preslar, Hani Katerji, Christopher Palma, Scott J. Cameron> ;The American Journal of Medicine. 2020 Jul 1
20 citations
Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice
Christopher Palma, Michael G. Overstreet, Jean Marc Guedon, Egbert Hoiczyk, Cameron Ward, Kasey A. Karen, Fidel Zavala, Gary Ketner> ;Vaccine. 2011 Feb 11
Join now to see all

Journal Articles

Characterization of di-, tri-, and tetranucleotide microsatellite markers with perfect repeats for Trypanosoma brucei and related species
Balmer O; Palma C; Macleod A; Caccone A, Molecular Ecology Notes, 1/1/2006

Abstracts/Posters

Anakinra is effecitve and well tolerated in medically complex patients including transplant recipients with gout.
Christopher Palma, Taylor Topping, Darren Tabechain, American College of Rheumatology Annual Meeting, 1/1/2016

Lectures